Search Results
Early use of high-efficacy therapies in people with MS: What is holding us back? |MS Academy Webinar
Utilizing Early, High-Efficacy Therapies to Improve Outcomes in RRMS
Style Of Treatment: ESCALATION
Highly Effective Disease-Modifying Therapies for Multiple Sclerosis
Treating MS Early: Who, How, and When?
Long-term results of ocrelizumab in treatment-naive patients with early relapsing MS
MS Research 2019: Escalation v Early Intense Disease Modifying Therapy
Debate session Patients on low-efficacy DMTs should be allowed to switch... | MS Academy webinar
Changes in the MS treatment landscape over the last 2 years
Starting & switching DMTs | EAN 2020 summary by Multiple Sclerosis Academy
MS Relapses : Attack of the Immune System - Ben Thrower, M.D. - October 2015
What's New in MS Research: A Look Into the Future of Multiple Sclerosis Treatment - July 2021
